Litcius/Paper detail

Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One

Alessandra Salerno, Francesca Seghetti, Jessica Caciolla, Elisa Uliassi, Eleonora Testi, Melissa Guardigni, Marinella Roberti, Andrea Milelli, María Laura Bolognesi

2022Journal of Medicinal Chemistry47 citationsDOIOpen Access PDF

Abstract

PROTACs. A deeper and detailed understanding of the most critical challenges is required to fully exploit these opportunities and decisively enrich the PROTAC toolbox.

Topics & Concepts

ProteolysisChemistryModalitiesTherapeutic modalitiesDrug discoveryChimera (genetics)Computational biologyTreatment modalityModality (human–computer interaction)BiochemistryArtificial intelligenceComputer scienceEnzymeInternal medicineBiologyMedicineSocial scienceSociologyGeneProtein Degradation and InhibitorsUbiquitin and proteasome pathwaysMultiple Myeloma Research and Treatments
Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One | Litcius